Founded Date: 2013
Technology: Anti-infective Drugs
Investor Type: For Profit
Funding Status: Late Stage Venture
Total Funding: $236.5M
Employee Number: 101-250
Headquarters: San Diego, California, United States
Investors Number: 12
Last Funding Type: Series B
Estimated Revenue: $50M to $100M
Industry: PharmTech